Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016
OTC Pharmaceuticals Market in the APAC region to grow at a CAGR of 3.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals market in the APAC region has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the product recalls by the US FDA could pose a challenge to the growth of this market.
OTC Pharmaceuticals Market in the APAC Region 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the APAC region; it also covers the OTC Pharmaceuticals market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Johnson & Johnson, GlaxoSmithKline plc, Novartis International AG, and Bayer Healthcare AG.
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH, Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., and Schering-Plough Corp., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
OTC Pharmaceuticals Market in the APAC Region 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the APAC region; it also covers the OTC Pharmaceuticals market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Johnson & Johnson, GlaxoSmithKline plc, Novartis International AG, and Bayer Healthcare AG.
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH, Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., and Schering-Plough Corp., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
